日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Spatial Immune Profiling and AI-Based Classifiers Identify Predictors of BCG Therapy Outcomes in High-Risk Non-Muscle-Invasive Bladder Cancer.

空间免疫分析和基于人工智能的分类器可识别高危非肌层浸润性膀胱癌中 BCG 治疗结果的预测因子。

Lillesand Melinda, Austdal Marie, Mroz Jakub, Skaland Ivar, Gudlaugsson Einar, Jong Florus C de, Zuiverloon Tahlita C M, Engan Kjersti, Janssen Emiel A M

PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCG

在高危非肌层浸润性膀胱癌中,PD-L1表达并非卡介苗疗效的生物标志物。

de Jong, Florus C; Kvikstad, Vebjørn; Hoedemaeker, Robert F; van der Made, Angelique C J; van der Bosch, Thierry P; van Casteren, Niels J; van Kessel, Kim E M; Zwarthoff, Ellen C; Boormans, Joost L; Zuiverloon, Tahlita C M

Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin

非肌层浸润性膀胱癌分子亚型可预测对膀胱内卡介苗的不同反应

de Jong, Florus C; Laajala, Teemu D; Hoedemaeker, Robert F; Jordan, Kimberley R; van der Made, Angelique C J; Boevé, Egbert R; van der Schoot, Deric K E; Nieuwkamer, Bart; Janssen, Emiel A M; Mahmoudi, Tokameh; Boormans, Joost L; Theodorescu, Dan; Costello, James C; Zuiverloon, Tahlita C M

High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes

针对分子膀胱癌亚型的高内涵药物发现

Sébastien Rinaldetti, Qiong Zhou, Joshua M Abbott, Florus C de Jong, Hector Esquer, James C Costello, Dan Theodorescu, Daniel V LaBarbera

Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy

膀胱癌代谢重编程在免疫疗法疗效中的作用

Scholtes, Mathijs P; de Jong, Florus C; Zuiverloon, Tahlita C M; Theodorescu, Dan

Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell Lines

系统综述:膀胱癌细胞系的特征和临床前应用

Zuiverloon, Tahlita C M; de Jong, Florus C; Costello, James C; Theodorescu, Dan